NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) short interest & short volume · 25.7% of float short
NewAmsterdam Pharma Company N.V. Ordinary Shares official short interest (FINRA, twice monthly) and daily short volume (FINRA Reg SHO), with history, % of float and days to cover.
What changed
NAMS short interest fell 25.9% to 14.1M shares in the Oct 15, 2026 report (25.7% of float, 10.6 days to cover). Daily short volume averaged 39.4% of volume over the last 20 sessions, down from 53.0% the 20 sessions before, the 1st percentile of its own 20-day averages since Oct 6, 2025.
Short interest
Official, twice monthly · settled Oct 15, 2026
- Shares short
- 14.1M
- prior 19.0M
- % of float
- 25.7%
- float 54.9M
- Days to cover
- 10.6
- avg vol 1.3M
- Change vs prior report
- -25.9%
| Report date | Shares short | $ value short | Change | % float | Days to cover | Price |
|---|---|---|---|---|---|---|
| Oct 15, 2026 | 14.1M | $290.9M | -25.9% | 25.7% | 10.6 | $20.62 |
| Sep 30, 2026 | 19.0M | $463.2M | +21.6% | 34.7% | 9.4 | $24.32 |
| Sep 15, 2026 | 15.7M | $331.4M | +16.9% | 28.5% | 9.9 | $21.16 |
| Aug 31, 2026 | 13.4M | $339.4M | +5.8% | 24.4% | 13.4 | $25.34 |
| Aug 14, 2026 | 12.7M | $341.4M | +27.1% | 23.1% | 9.9 | $26.98 |
| Jul 31, 2026 | 10.0M | $276.8M | +8.5% | 18.1% | 9.8 | $27.79 |
Days to cover is short interest divided by FINRA's average daily volume for the period: how many average days of trading it would take shorts to buy back.
% of float uses the current float for every report (no float was stored with older reports).
Source: FINRA equity short interest (twice monthly) · Settlement Oct 15, 2026
Daily short volume
Share of each day's volume sold short · FINRA Reg SHO
- Latest (Nov 11)
- 49.9%
- 769K of 1.5M
- 20-day average
- 39.4%
- prior 53.0%
- Percentile vs own history
- 1st
- 233 periods since 2025
Loading prices…
Source: FINRA Reg SHO daily short sale volume · Latest Nov 11, 2026
Short squeeze score (model)
Price since settlement: -3.2%
Model, not a forecast: 40 pts short interest % of float (full at 30%), 25 pts days to cover (full at 10), 15 pts rise in short interest since the prior report (full at +50%), 20 pts price gain since the settlement date (full at +25%). Missing inputs score 0.
NAMS's squeeze score and its inputs with Lician Pro.Start 3-day trial — $149/yr
Market-wide: most shorted stocks, biggest changes and unusual short volume · NAMS overview
| Date | Short | Total | Short % of volume |
|---|---|---|---|
| 2026-11-11 | 768,535 | 1,539,140 | 49.9% |
| 2026-11-10 | 545,924 | 1,453,978 | 37.5% |
| 2026-11-09 | 452,459 | 1,357,019 | 33.3% |
| 2026-11-06 | 335,802 | 698,259 | 48.1% |
| 2026-11-05 | 247,796 | 592,234 | 41.8% |
| 2026-11-04 | 163,723 | 975,868 | 16.8% |
| 2026-11-03 | 411,315 | 1,056,203 | 38.9% |
| 2026-11-02 | 455,398 | 973,282 | 46.8% |
| 2026-10-30 | 216,472 | 500,953 | 43.2% |
| 2026-10-29 | 137,623 | 479,230 | 28.7% |
Healthcare peers with similar quant ratings
NAMS is rated 1.05 of 5 among 545 rated Healthcare stocks (Lician quant rating, Nov 13, 2026). How the rating works
- SVRA short interest1.08 · Strong Sell · stock
- AQST short interest1.07 · Strong Sell · stock
- AXSM short interest1.06 · Strong Sell · stock
- SNDX short interest1.06 · Strong Sell · stock
- RGC short interest1.04 · Strong Sell
- NGEN short interest1.03 · Strong Sell
- PROK short interest1.03 · Strong Sell · stock
- RNAC short interest1.02 · Strong Sell · stock
NAMS short interest FAQ
What is NAMS's short interest?
NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) had 14.1M shares sold short and not yet covered in FINRA's Oct 15, 2026 settlement report, 25.7% of its 54.9M-share float.
How many days to cover does NAMS have?
10.6 days: 14.1M shares short divided by an average daily volume of 1.3M for the Oct 15, 2026 period.
Is NAMS short interest rising or falling?
NAMS short interest fell (-25.9%) from 19.0M to 14.1M shares in the Oct 15, 2026 report.
Is NAMS a short squeeze candidate?
Lician's squeeze watch scores NAMS 59 out of 100 (elevated) from the Oct 15, 2026 report: short interest % of float 34.3/40, days to cover 25/25, change in short interest vs prior report 0/15, price change since settlement date 0/20. It is a transparent model of how crowded the short side is, not a forecast that a squeeze will happen.
What share of NAMS daily volume is sold short?
39.4% on average over the last 20 sessions to Nov 11, 2026 (FINRA Reg SHO daily short volume; the 1st percentile of its own 20-day averages). Short volume counts market makers' same-day short sales, so it is not short interest.
What was NAMS's latest FINRA short volume?
On Nov 11, 2026, cached FINRA short volume for NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) was 768,535 shares, 49.9% of 1,539,140 total volume.
How many NAMS short-volume sessions are listed on this page?
This page lists 10 cached FINRA short-volume sessions for NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS), from Oct 29, 2026 through Nov 11, 2026.
How did NAMS short volume percent change from the prior cached session?
Cached FINRA short volume for NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) moved from 37.5% on Nov 10, 2026 to 49.9% on Nov 11, 2026, up 12.4 percentage points.
Not investment advice. Figures as filed or reported, not a live feed.